The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus

Clinical Microbiology and Infection

Volumn 12, Issue SUPPL. 1, 2006, Pages 16-23

  Appelbaum, P C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Antibiotic; Methicillin resistant Staphylococcus aureus; Review; Vancomycin non susceptible Staphylococcus aureus; Vancomycin resistant enterococci

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CLINDAMYCIN; ERYTHROMYCIN; HABEKACIN; MACROLIDE; METICILLIN; NEW DRUG; OXACILLIN; POLYPEPTIDE ANTIBIOTIC AGENT; RIFAMPICIN; SULTAMICILLIN; TEICOPLANIN; VANCOMYCIN;

AGE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; AUTOMATION; BACTERIAL CELL WALL; DEBRIDEMENT; DRUG EFFICACY; EPIDEMIC; FOOT ULCER; GENE TRANSFER; HEALTH CARE SYSTEM; HOSPITAL INFECTION; HUMAN; INFECTION RISK; LEG BLOOD FLOW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; NONHUMAN; PHYSICIAN; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SKIN ABSCESS; STAPHYLOCOCCUS INFECTION; COMMUNICABLE DISEASE; CROSS INFECTION; DISEASE TRANSMISSION; DRUG EFFECT; GENETICS; HETEROZYGOTE; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; PHYSIOLOGY; STANDARD; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CARRIER STATE; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 33645749939     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01344.x     Document Type: Review

References (37)

1. Centers for Disease Control and Prevention. VISA/VRSA: vancomycin-intermediate/resistant Staphylococcus aureus. http://www.cdc.gov/ncidod/hip/aresist/visa.htm
2. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004: Issued October 2004. Am J Infect Control 2004; 32: 470-485.
3. Tiemersma EW, Bronzwaer SL, Lyytikäinen O et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004; 10: 1627-1634.
4. Diep BA, Sensabaugh GF, Somboona NS, Carleton HA, Perdreau-Remington F. Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin. J Clin Microbiol 2004; 42: 2080-2084.
5. Francis JS, Doherty MC, Lopatin U et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005; 40: 100-107.
6. Kazakova SV, Hageman JC, Matava M et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 2005; 352: 468-475.
7. Shukla SK. Community-associated methicillin-resistant Staphylococcus aureus and its emerging virulence. Clin Med Res 2005; 3: 57-60.
8. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135-136.
9. Smith TL, Pearson ML, Wilcox KR et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-intermediate Staphylococcus aureus Working Group. N Engl J Med 1999; 340: 493-501.
10. Sancak B, Ercis S, Menemenlioglu D, Colakoglu S, Hascelik G. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital. J Antimicrob Chemother 2005; 56: 519-523.
11. Rudrick J T. Michigan Department of Community Health. http://www.michigan.gov/documents/VRSA_Feb05_HAN_118391_7.pdf
12. Kacica M, McDonald LC. Brief report: Vancomycin-resistant Staphylococcus-aureus - New York, 2004. MMWR 2004; 53: 322-323.
13. Chang S, Sievert DM, Hageman JC et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003; 348: 1342-1347.
14. Tenover FC, Weigel LM, Appelbaum PC et al. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother 2004; 48: 275-280.
15. Healy CM, Hulten KG, Palazzi DL, Campbell JR, Baker CJ. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis 2004; 39: 1460-1466.
16. Carleton HA, Diep BA, Charlebois ED, Sensabaugh GF, Perdreau-Remington F. Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis 2004; 190: 1730-1738.
17. Crisostomo MI, Westh H, Tomasz A, Chung M, Oliveira DC, de Lencastre H. The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones. Proc Natl Acad Sci USA 2001; 98: 9865-9870.
18. Centers for Disease Control and Prevention. Laboratory detection of vancomycin-intermediate/resistant Staphylococcus aureus (VISA/VRSA). http://www.cdc.gov/ncidod/hip/Laboratory/FactSheet/vrsa.htm
19. Howden BP, Ward PB, Charles PG et al. Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis 2004; 38: 521-528.
20. Srinivasan A, Dick JD, Perl TM. Vancomycin resistance in staphylococci. Clin Microbiol Rev 2002; 15: 430-438.
21. Menichetti F. Current and emerging serious Gram-positive infections. Clin Microbiol Infect 2005; 11 (suppl 3): 22-28.
22. Hiramatsu K, Aritaka N, Hanaki H et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350: 1670-1673.
23. Hiramatsu K. Vancomycin-resistant Staphylococcus aureus: A new model of antibiotic resistance. Lancet Infect Dis 2001; 1: 147-155.
24. Sieradzki K, Pinho MG, Tomasz A. Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus. J Biol Chem 1999; 274: 18942-18946.
25. Lowy FD. Antimicrobial resistance: The example of Staphylococcus aureus. J Clin Invest 2003; 111: 1265-1273.
26. Cui L, Murakami H, Kuwahara-Arai K, Hanaki H, Hiramatsu K. Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob Agents Chemother 2000; 44: 2276-2285.
27. Cui L, Ma X, Sato K et al. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol 2003; 41: 5-14.
28. Sieradzki K, Roberts RB, Haber SW, Tomasz A. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med 1999; 340: 517-523.
29. Sieradzki K, Tomasz A. Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus. J Bacteriol 2003; 185: 7103-7110.
30. Weigel LM, Clewell DB, Gill SR et al. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 2003; 302: 1569-1571.
31. Sievert DM, Boulton ML, Stoltman G et al. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR 2002; 51: 565-567.
32. Miller D, Urdaneta V, Weltman A, Park S. Public health dispatch: vancomycin-resistant Staphylococcus aureus - Pennsylvania, 2002. MMWR 2002; 51: 902.
33. Palazzo IC, Araujo ML, Darini AL. First report of vancomycin-resistant staphylococci isolated from healthy carriers in Brazil. J Clin Microbiol 2005; 43: 179-185.
34. Perl TM. The threat of vancomycin resistance. Am J Med 1999; 106: 26S-37S.
35. Bozdogan B, Esel D, Whitener C, Browne FA, Appelbaum PC. Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical Center. J Antimicrob Chemother 2003; 52: 864-868.
36. Appelbaum PC, Bozdogan B. Vancomycin resistance in Staphylococcus aureus. Clin Lab Med 2004; 24: 381-402.
37. Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med 2000; 342: 710-721.